Home Search
- search results
If you're not happy with the results, please do another search
Treatment delays and staff shortages put cancer lives at risk in UK
Lives in the UK are being put at risk by delays to essential chemotherapy treatment and a shortages of cancer nurses, medical leaders have...
SAMA slams surprise parliamentary visit to Khayelitsha Hospital
Parliament's select committee on petitions and executive undertakings has come under fire from the SA Medical Association (SAMA) for conducting an unannounced visit to...
Cuba/SA medical student programme a 'headache' – Motsoaledi
SA's massive programme for training medical students in Cuba‚ was so large that it had become a headache for both countries and a decision...
NW Health head suspended over Gupta-linked contract
North West Premier Supra Mahumapelo has suspended the Health Department's head, Dr Andrew Thabo Lekalakala, over a contract given to Gupta-linked healthcare company Mediosa....
Surge of complaints to SA"s health standards compliance office
The Office of Health Standards Compliance (OHSC) has seen a surge in complaints to its consumer hotline in the wake of the Life Esidimeni...
KZN Health MEC must account to human rights body over oncology crisis
The head of the KwaZulu-Natal Health Department, MEC Sibongiseni Dhlomo, has been issued with a notice to appear before the South African Human Rights...
Mesh surgery exposed UK women to 'unacceptable risk'
Women have been exposed to unacceptable risks through the use of vaginal mesh surgery, the UK government has acknowledged for the first time, as...
SA civil society groups want UNAIDS director to resign
The director of UNAIDS, Michel Sidibé, is facing calls from South African civil society groups to resign over his handling of a recent sexual...
Immunotherapy and chemo drug combo increases lung cancer survival rates
The immunotherapy drug pembrolizumab, when combined with chemotherapy, doubles survival in patients with non-squamous non-small cell lung cancer (NSNSCLC) lacking genetic changes in the...
Investigational drug safely and effectively treats RET-driven cancers
A phase I, first-in-human study led by The University of Texas MD Anderson Cancer Centre reveals for the first time, an investigational drug that...